Quick Answer
Adagene Inc. reported R&D Expense of $28.78 million for fiscal year 2024.
Adagene Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $28.78M | -21.4% |
| 2023 | $36.64M | -55.0% |
| 2022 | $81.34M | +19.4% |
| 2021 | $68.10M | +103.1% |
| 2020 | $33.54M | +106.9% |
| 2019 | $16.21M | +0.8% |
| 2018 | $16.08M | — |
- Adagene Inc. showed a decrease of -21.4% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2024 period, Adagene Inc.’s r&d expense has grown by 79.0% (from $16.08 million to $28.78 million).
- The most recent figure is from Adagene Inc.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: